FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 310:1079-1084 April 26, 1984 Number 17 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Aluminum intoxication developed in three infants with azotemia who were not undergoing dialysis and who had been treated with aluminum hydroxide from the first month of life. Biopsies of the iliac crest demonstrated the presence of severe osteomalacia and massive deposition of aluminum in the bone. Serum aluminum levels were significantly (P less than 0.001) higher in these 3 infants and in 1 other, all of whom received more than 100 mg of elemental aluminum per kilogram of body weight per day (mean +/- S.D., 371.0 +/- 178.9 ng per milliliter [13.75 +/- 6.6 mumol per liter] ) than they were in 8 older children with azotemia who were not undergoing dialysis and who received less than 100 mg of elemental aluminum per kilogram per day (27.0 +/- 18.6 ng per milliliter [1.0 +/- 0.68 mumol per liter] ), 7 such children who did not receive aluminum hydroxide (20.28 +/- 9.2 ng per milliliter [0.75 +/- 0.34 mumol per liter] ), and 16 children with normal renal function (21.04 +/- 4.9 ng per milliliter [0.78 +/- 0.18 mumol per liter] ). In all the children with azotemia who were treated with aluminum hydroxide, there was a positive correlation (r = 0.90; P less than 0.01) between the serum aluminum level and the daily dose of elemental aluminum. These studies indicate that gastrointestinal absorption of aluminum can lead to aluminum intoxication in children with azotemia, and that infants may be particularly susceptible to this complication of therapy.

This article has been cited by other articles:

• Duquette, P. J., Hooper, S. R., Icard, P. F., Hower, S. J., Mamak, E. G., Wetherington, C. E., Gipson, D. S. (2009). Neurodevelopmental Status and Adaptive Behaviors in Preschool Children with Chronic Kidney Disease. Journal of Special Education 43: 45-51 [Abstract]  
• Chua, A. N., Sarwal, M. M. (2005). Acute Renal Failure Management in the Neonate. NeoReviews 6: e369-e376 [Full Text]  
• Robinson, R. F, Casavant, M. J, Nahata, M. C, Mahan, J. D (2004). Metabolic Bone Disease After Chronic Antacid Administration in an Infant. The Annals of Pharmacotherapy 38: 265-268 [Abstract] [Full Text]  
• Salusky, I. B., Goodman, W. G. (2000). Managing phosphate retention: is a change necessary?. Nephrol Dial Transplant 15: 1738-1742 [Full Text]  
• Yen-Koo, H. C. (1992). The Effect of Aluminum On Conditioned Avoidance Response (Car) in Mice. Toxicol Ind Health 8: 1-7 [Abstract]  
• Hanna, J. D., Foreman, J. W., Chan, J. C.M. (1991). Chronic Renal Insufficiency in Infants and Children. CLIN PEDIATR 30: 365-384  
• Brem, A. S., DiMario, C., Levy, D. L. (1989). Perceived Aluminum-Related Disease in a Dialysis Population: A Report From the End-Stage Renal Disease Network 28. Arch Intern Med 149: 2541-2544 [Abstract]  
• Bozynski, M. E. A., Sedman, A. B., Naglie, R. A., Wright, E. J. (1989). Serial Plasma and Urinary Aluminum Levels and Tissue Loading in Preterm Twins. JPEN J Parenter Enteral Nutr 13: 428-431 [Abstract]  
• Koo, W., Kaplan, L., Krug-Wispe, S. (1988). Response to Letter from Dr. Moore. JPEN J Parenter Enteral Nutr 12: 535-536  
• Fraser, C. L., Arieff, A. I. (1988). Nervous System Complications in Uremia. ANN INTERN MED 109: 143-153 [Abstract]